Y Intercept Hong Kong Ltd Acquires New Shares in The Clorox Company $CLX

Y Intercept Hong Kong Ltd purchased a new position in The Clorox Company (NYSE:CLX) during the first quarter, HoldingsChannel.com reports. The fund purchased 31,119 shares of the company’s stock, valued at approximately $3,225,000.

A number of other large investors also recently modified their holdings of CLX. Wilkins Investment Counsel Inc. grew its position in Clorox by 250.6% during the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after buying an additional 39,360 shares in the last quarter. Morningstar Investment Management LLC increased its position in shares of Clorox by 131.8% in the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after purchasing an additional 35,506 shares during the last quarter. Swiss Life Asset Management Ltd raised its stake in Clorox by 221.4% in the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock valued at $10,656,000 after purchasing an additional 59,533 shares in the last quarter. National Pension Service lifted its position in Clorox by 68.9% during the fourth quarter. National Pension Service now owns 27,537 shares of the company’s stock valued at $2,777,000 after purchasing an additional 11,233 shares during the last quarter. Finally, Birch Hill Investment Advisors LLC purchased a new position in Clorox in the 4th quarter worth approximately $22,103,000. 78.53% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently issued reports on CLX shares. Barclays dropped their price objective on shares of Clorox from $102.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $91.00 price objective on shares of Clorox in a report on Friday, May 1st. UBS Group reduced their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. Royal Bank Of Canada dropped their target price on Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research report on Thursday, April 9th. Finally, Evercore reaffirmed an “underperform” rating and issued a $110.00 target price on shares of Clorox in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat.com, Clorox has an average rating of “Reduce” and an average price target of $103.40.

Insider Activity

In other news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, for a total transaction of $429,100.00. Following the purchase, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.63% of the stock is currently owned by corporate insiders.

Clorox Stock Up 1.1%

NYSE:CLX traded up $1.10 during mid-day trading on Tuesday, hitting $98.35. 499,548 shares of the company’s stock were exchanged, compared to its average volume of 2,534,383. The company has a market cap of $11.89 billion, a PE ratio of 15.95, a P/E/G ratio of 0.46 and a beta of 0.54. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The Clorox Company has a one year low of $84.70 and a one year high of $132.03. The business has a fifty day moving average price of $94.22 and a 200 day moving average price of $104.24.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s revenue for the quarter was up .1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts predict that The Clorox Company will post 5.61 EPS for the current year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.